openPR Logo
Press release

Glycated Haemoglobin Testing Market Revenue Predicted to Go Up by 2020 - PMR Report

05-17-2017 03:56 PM CET | Health & Medicine

Press release from: Persistence Market Research

Glycated Haemoglobin Testing Market Revenue Predicted to Go Up

Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in the patients. Glycated haemoglobin test is used for diagnosis and monitoring of Haemoglobin A1c levels in diabetic patient. Glycated haemoglobin test reflects the average amount of glucose for the past 2 to 3 months in diabetic patients. It helps to determine the how well the level of glucose is controlled over time.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3219

North America dominates the global market for glycated haemoglobin testing due high diabetic prevalence and easily accessible modern healthcare facilities. Asia Pacific followed by the Europe is expected to show high growth rates in the next five years in global glycated haemoglobin testing market. Some of the key driving forces for glycated haemoglobin testing market in emerging countries are increasing prevalence of diabetics and increasing awareness about diabetics.

In recent times there is increased use of glycated haemoglobin testing due to increasing incidence of diabetics among the population. Growing awareness of haemoglobin A1c testing among patients and medical practitioners and aging population are some of the key factors driving the growth for global glycated haemoglobin testing market. In addition, increasing healthcare awareness is also fuelling the growth of global glycated haemoglobin testing market. However, presences of substitutes such as test strips, glucose meters, lancets and continuous blood glucose meter for monitoring diabetes and high test cost are some of the major factors restraining the growth for global glycated haemoglobin testing market.

Increasing healthcare facilities would lead to growth in glycated haemoglobin testing market in Asia. In addition, rapid commercialization of devices for diabetes testing would develop opportunity for global glycated haemoglobin testing market. However, presence of limited approval for assay of glycated haemoglobin testing could lead a challenge for global glycated haemoglobin testing market.

Some of the trends for global glycated haemoglobin testing market are increasing mergers and acquisitions, which would help in improving measurement of glycated haemoglobin and point of care haemoglobin A1c testing.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/3219

Some of the major companies operating in the global glycated haemoglobin testing market are Abbott Laboratories, Roche Holdings AG, Alere Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Bayer AG, ARKRAY Inc., Randox Laboratories Ltd., Tosoh Corp. and A. Menarini Diagnostics Ltd.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Glycated Haemoglobin Testing Market Revenue Predicted to Go Up by 2020 - PMR Report here

News-ID: 539337 • Views:

More Releases from Persistence Market Research

Smart Door Lock Market Anticipated to Hit USD 9.89 Billion by 2032
Smart Door Lock Market Anticipated to Hit USD 9.89 Billion by 2032
The global smart door lock market is experiencing transformative growth as consumer demand for security, convenience, and smart home integration intensifies. The market size is projected to increase from US$ 3,059.7 Mn in 2025 to US$ 9,890.6 Mn by 2032, registering a robust CAGR of 18.3% during the forecast period. Rising concerns about home and workplace security, combined with rapid technological innovations, are fueling the adoption of smart door locks.
Diisononyl Phthalate Market to Reach US$4.6 Bn by 2031 Driven by Rising Demand in Flexible PVC Applications
Diisononyl Phthalate Market to Reach US$4.6 Bn by 2031 Driven by Rising Demand i …
The global Diisononyl Phthalate (DINP) market is undergoing a steady expansion, shaped by evolving industrial applications, regulatory dynamics, and technological innovations in plasticizers. As a key phthalate plasticizer, DINP is predominantly used in the production of flexible polyvinyl chloride (PVC) products. Its superior durability, flexibility, and resistance to weathering make it indispensable across a wide range of industries, from construction and automotive to consumer goods. According to the latest study by
Propylene Carbonate Market to Reach US$468.2 Mn by 2031, Driven by Rising Demand in Electronics and Battery Applications
Propylene Carbonate Market to Reach US$468.2 Mn by 2031, Driven by Rising Demand …
The global propylene carbonate market is entering a promising growth phase, fueled by rising demand across multiple industries, particularly in electronics, automotive, and paints & coatings. Propylene carbonate, a highly versatile organic compound, is widely recognized for its exceptional solvent properties, biodegradability, and low toxicity, making it a preferred choice in green chemistry applications. According to the latest study by Persistence Market Research, the market is expected to grow from US$275.5
Flexible Electronics Market Anticipated to Hit USD 5,880.6 Million by 2030
Flexible Electronics Market Anticipated to Hit USD 5,880.6 Million by 2030
The Global Flexible Electronics Market is forecasted to expand at a CAGR of 11.4%, increasing from a value of US$ 2,762.0 million in 2023 to US$ 5,880.6 million by 2030. Flexible electronics is transforming the conventional electronics industry by integrating lightweight, bendable, and conformable devices into everyday life. These technologies are being widely adopted across consumer electronics, healthcare, automotive, and wearable technology sectors, promising increased portability, efficiency, and user-friendly designs. Elevate

All 5 Releases


More Releases for Haemoglobin

Glycated Haemoglobin Testing Market to Reach USD 6.2 Billion by 2034
The global burden of diabetes is increasing at an unprecedented rate, and effective monitoring of blood glucose levels has become critical in managing this chronic disease. Among the most reliable tools in diabetes care is glycated haemoglobin (HbA1c) testing, which measures average blood sugar levels over two to three months. Unlike daily glucose monitoring, HbA1c testing provides a long-term perspective, making it a gold standard for diagnosing and managing diabetes. Download
Haemoglobin Production Cost Report by Procurement Resource
Procurement Resource, a global leader in procurement intelligence and market analysis, is pleased to release its latest Haemoglobin Production Cost Report-a strategic tool for companies, researchers, investors, and healthcare manufacturers looking to explore or expand haemoglobin production capabilities. This detailed report delves into the technical, economic, and regulatory aspects of haemoglobin production, offering stakeholders a clear view of cost structures, raw material requirements, production routes, infrastructure, and profitability. With the growing
Glycated Haemoglobin Testing Equipment Market Size 2024 to 2031.
Market Overview and Report Coverage Glycated Haemoglobin Testing Equipment is used to measure the level of glycated hemoglobin in the blood, which is a crucial indicator for managing diabetes. The market for glycated haemoglobin testing equipment is expected to witness significant growth in the coming years, with a projected CAGR of 8.60% during the forecasted period. The increasing prevalence of diabetes worldwide, coupled with the rising awareness about the
Glycated Haemoglobin Testing Market Estimated to Record Highest CAGR by 2020
Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in the patients. Glycated haemoglobin test is used for diagnosis and monitoring of Haemoglobin A1c levels in diabetic patient. Glycated haemoglobin test reflects the average amount of glucose for the past 2 to 3 months in diabetic patients. It helps to
Global Glycated Haemoglobin Testing Market
The Glycated Haemoglobin Testing Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in
Analysis of Global Glycated Haemoglobin Testing Market by 2020
Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in the patients. Glycated haemoglobin test is used for diagnosis and monitoring of Haemoglobin A1c levels in diabetic patient. Glycated haemoglobin test reflects the average amount of glucose for the past 2 to 3 months in diabetic patients. It helps to